Additional recall developments have occurred involving fentanyl pain patches. On February 18, Actavis, Inc. announced a recall of 14 lots of its patches, due to a fold-over defect that may cause leaks that expose patients directly to the fentanyl gel. Previously, a Johnson & Johnson subsidiary recalled certain lots of its fentanyl patches, marketed under the name of Duragesic.The FDA stated...